These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. The influence of haloperidol and penfluridol on the learning capacity of the schizophrenic. Van Lommel R, Baro F, Dom R. Arzneimittelforschung; 1974 Jul; 24(7):1072-4. PubMed ID: 4605278 [No Abstract] [Full Text] [Related]
10. Pimozide treatment of chronic schizophrenics as compared with haloperidol and penfluridol maintenance treatment. A multidisciplinary approach. Baro F, Van Lommel R, Dom R, De Mesmaecker L. Acta Psychiatr Belg; 1972 Mar; 72(2):199-214. PubMed ID: 5056015 [No Abstract] [Full Text] [Related]
11. Safety evaluation of penfluridol, a new long-acting oral antipsychotic agent. Ota KY, Kurland AA, Slotnick VB. J Clin Pharmacol; 1974 Apr; 14(4):202-9. PubMed ID: 4595986 [No Abstract] [Full Text] [Related]
12. [Clinical study on five depot neuroleptics. Comparison of effective profiles of fluphenazinedecanoate, fluspirilene, penfluridol, perphenazine-enanthate and pipothiazinepalmitate]. Angst J, Woggon B. Arzneimittelforschung; 1975 Feb; 25(2):267-70. PubMed ID: 1091272 [Abstract] [Full Text] [Related]
13. [Long term treatment of schizophrenia with penfluridol]. Haring C. Med Welt; 1977 Apr 01; 28(13):639-42. PubMed ID: 404499 [No Abstract] [Full Text] [Related]
14. The use of an oral long-acting anti-psychotic agent, penfluridol, in schizophrenia. White AC, Sims AC. Curr Med Res Opin; 1974 Apr 01; 2(1):23-6. PubMed ID: 4841811 [No Abstract] [Full Text] [Related]